NK-like Cell Platform
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
134
NCT05207371
Clinical Trial of GAIA-102 for Advanced and Relapse NSCLC
Phase: Phase 1/2
Role: Lead Sponsor
Start: Dec 1, 2021
Completion: Dec 1, 2025
NCT05438459
GAIA-102 Intraperitoneal Administration in Patients With Advanced Gastrointestinal Cancer of Microsatellite Stable With Malignant Ascites
Role: Collaborator
Start: Jun 8, 2022
Completion: Jun 8, 2027
Loading map...